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Abstract
Background: Cryptococcus neoformans has a predilection for central nervous system infection. C. neoformans
traversal of the blood brain barrier, composed of human brain microvascular endothelial cells (HBMEC), is the
crucial step in brain infection. However, the molecular mechanism of the interaction between Cryptococcus
neoformans and HBMEC, relevant to its brain invasion, is still largely unknown.
Methods: In this report, we explored several cellular and molecular events involving the membrane lipid rafts and
caveolin-1 (Cav1) of HBMEC during C. neoformans infection. Immunofluorescence microscopy was used to examine
the roles of Cav1. The knockdown of Cav1 by the siRNA treatment was performed. Phosphorylation of Cav1
relevant to its invasion functions was investigated.
Results: We found that the host receptor CD44 colocalized with Cav1 on the plasma membrane, and knockdown
of Cav1 significantly reduced the fungal ability to invade HBMEC. Although the CD44 molecules were still present,
HBMEC membrane organization was distorted by Cav1 knockdown. Concomitantly, knockdown of Cav1
significantly reduced the fungal crossing of the HBMEC monolayer in vitro. Upon C. neoformans engagement, host
Cav1 was phosphorylated in a CD44-dependent manner. This phosphorylation was diminished by filipin, a disrupter
of lipid raft structure. Furthermore, the phosphorylated Cav1 at the lipid raft migrated inward to the perinuclear
localization. Interestingly, the phospho-Cav1 formed a thread-like structure and colocalized with actin filaments but
not with the microtubule network.
Conclusion: These data support that C. neoformans internalization into HBMEC is a lipid raft/caveolae-dependent
endocytic process where the actin cytoskeleton is involved, and the Cav1 plays an essential role in C. neoformans
traversal of the blood-brain barrier.
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Background
Cryptococcus neoformans is commonly found in the
environment, such as in the soil and in bird droppings.
These fungal cells may be inhaled and deposited into
the lungs and into the blood stream, providing a path
for C. neoformans to reach the brain. In the case of the
immunocompromised, this fungus could cause life-
threatening cryptococcal meningitis [1,2]. In the world
today, cryptococcal infection has become the most com-
mon fungal pathogen of the central nervous system [3].
In order to cause meningoencephalitis, the fungal cells
must cross the blood-brain barrier (BBB). A special type
of cell constitutes the BBB, the brain microvascular
endothelial cells (BMEC), which are characterized by
extremely tight intercellular junctions [4]. The large sur-
face of BMEC exposed to blood circulation (~20 m
2 per
human brain) underscores the importance of the BBB as
the critical limiting factor for C. neoformans brain
invasion.
Infection of C. neoformans into human brain micro-
vascular endothelial cells (HBMEC) requires adherence
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any medium, provided the original work is properly cited.to the host cell’s surface in order to resist the flow of
blood. It is generally accepted that the fungal capsule is
the major virulence factor of this pathogen (reviewed by
[5]). Real-time images have shown that the C. neofor-
mans cells may become trapped within the microvessels
in the brain, and subsequently, enter into the brain
through the parenchyma [6]. Several mechanisms are
possible for this transmigration process [6-12]. For
example, hyaluronic acid (HA), produced by the hya-
luronic acid synthase gene (CPS1)o fC. neoformans,
plays a role in the adhesion of the fungal cells to
endothelial cells [9,13]. We have demonstrated that
HBMEC CD44 is the primary receptor for C. neofor-
mans infection [14]. Accordingly, the adherence of
C. neoformans in the circulating blood to BMEC may be
secured by the C. neoformans-produced HA and
HBMEC CD44 interaction (the adhesion step). Then,
the fungal cell triggers host signaling pathway(s) to facil-
itate its internalization (the invasion step). One feature
of this process is the ability of C.n e o f o r m a n sto induce
morphological changes in HBMEC, such as: membrane
ruffling, irregular nuclear morphology and swelling of
t h em i t o c h o n d r i aa n dt h eE R[ 1 5 ] .T h e s ef i n d i n g ss u g -
gest that C. neoformans is able to induce actin cytoskeletal
reorganization of the host cells. Furthermore, activation of
host PKCa is essential for C. neoformans internalization
into HBMEC [10]. During C. neoformans infection, PKCa
activation by phosphorylation is induced and PKC enzy-
matic activity is detected in the HBMEC membrane frac-
tion. PKCa activation is a CPS1/CD44-dependent process.
Blockage of PKCa function attenuates actin filament activ-
ity during C. neoformans invasion. Moreover, treatment
with cytochalasin D, an actin disrupting reagent, can effec-
tively block C. neoformans invasion into HBMEC in vitro
[10]. Thus, the host PKCa action on C. neoformans inter-
nalization into HBMEC may be mediated via actin fila-
ment activity.
C. neoformans invasion into HBMEC is sensitive to the
filipin treatment [14], which extracts cholesterol from
membrane lipid rafts. It is generally accepted that endo-
cytosis is mediated by membrane lipids or rafts. We have
found that, in the presence of C. neoformans,t h e
HBMEC lipid raft marker ganglioside GM1 can influx
into the cytosol and accumulate in the perinuclear region
[16]. The uptake of GM1 suggests the involvement of
lipid raft endocytic pathways. An intriguing question
raised is how C. neoformans builds its distinct uptake
mechanism via lipid raft endocytic routes. This question
is complicated by the fact that endocytosis is comprised
of multiple mechanisms, i.e., caveolae-dependent, cla-
thrin-dependent mechanisms, pinocytosis, macropinocy-
tosis, and phagocytosis [17-19]. Upon C. neoformans and
HBMEC engagement, a subpopulation of CD44, Cav1,
and actin translocates to the host membrane rafts [14].
This link to dynamic caveolin trafficking suggests that
caveolae may play a role during the adhesion and entry
of C. neoformans at HBMEC membrane rafts.
Caveolae are small invaginations in the plasma mem-
brane that mediate multiple functions, including signal
transduction and endocytosis [19,20] and are character-
ized by the marker protein caveolins [21]. The mamma-
lian caveolin family contains three members: caveolin-1,
-2, and -3. Caveolin-2 is unable to form oligomers with-
out Cav1. Caveolin-3 (M-caveolin) is a muscle specific
member. Thus, Cav1 could be the critical caveolin in
HBMEC. Cav1 is also known as VIP21 (Vesicular Inte-
gral-membrane Protein of 21 kD); indeed, the protein
appears not only in the plasma membrane, but also on
the Golgi-apparatus and vesicular membrane structures.
The N-terminal region Cav1 contains the caveolin scaf-
folding domain (CSD; residues 82-101), which is essential
for the formation of caveolin oligomers as well as interac-
tion with other proteins. Abundant information reveals
that caveolin participates in many important cellular pro-
cesses, including vesicular trafficking, cholesterol home-
ostasis, cell adhesion and apoptosis [22]. Caveolins also
interact with multiple signaling molecules, and so, it is
believed that caveolins serve as scaffolding proteins for
the integration of signal transduction. At least 37 pro-
teins have been identified to interact with the CSD
domain of caveolin [23]. Moreover, some reports suggest
that the activity of caveolins seems to be dependent on
their specific post-translational modifications, which then
allow them to modulate cellular signaling cascades. For
example, the palmitoylation of Cav1 at a single site
(Cys156) was shown to be necessary for the coupling of
Cav1 to c-Src tyrosine kinase [24]. Also, phosphorylation
at Tyr14 is essential for caveolin association with SH2 or
PTB domain-containing adaptor proteins, such as GRB7
[25]. It is suggested that Cav1 stabilizes caveolae at the
plasma membrane and thereby acts as a negative regula-
tor of the internalization of caveolae or lipid raft-like
membrane domains [25]. Upon phosphorylation of
caveolin, caveolae are induced and then internalized by
endocytosis. However, the detailed mechanism of this
process remains to be further elucidated.
Our previous studies demonstrated that C. neoformans
adhesion to HBMEC takes place on the lipid rafts and
Cav1 may take part in the invasion process [14]. How-
ever, the role of caveolin during C. neoformans infection
has never been tested. In this report, we first examined
the impact of Cav1-knockdown on host receptor CD44
functions and on lipid rafts. Concurrently, the knock-
down of Cav1 significantly reduced C. neoformans inva-
sion and the crossing of the HBMEC monolayer in vitro.
We further examined the phosphorylation regulation of
Cav1 in response to C. neoformans invasion. Our studies
are the first to demonstrate that phosphorylated Cav1
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but not with the microtubule cytoskeleton. Together, our
results suggest that C. neoformans invasion into HBMEC
is linked to the lipid raft/caveolae-dependent endocytotic
process and that Cav1 plays an essential role during this
invasion process.
Methods
C. neoformans strains, media and cultures
The C. neoformans strain B-4500FO2 is the parental
strain used mainly in this report [9,13]. C559 is an iso-
genic deletion mutant of the CPS1 gene, which is
derived from strain B-4500FO2. C1186 is a strain B-
4500FO2 with a stable expression of GFP. This strain
was used in Figure 1 for the purpose of showing the
interaction between C. neoformans (green) and HBMEC
(red). In Figure 2C, the Cav1-GFP showed a green sig-
nal, therefore strain B-4500FO2 was used to stain with
anti-GXM antibody and the 2
nd antibody conjugated
with rhodamine (red). C. neoformans cells were grown
aerobically at 30°C in 1% yeast extract, 2% peptone and
2% dextrose (YPD broth)(Difco Laboratories, Detroit,
MI). Cells were harvested at early log phase, washed
with phosphate-buffered saline (PBS) and resuspended
in Hams-F12/M199 (1:1, v:v), 5% heat-inactivated fetal
bovine serum (experimental medium), and 1% human
serum. The Cryptococcus cell number was determined
by direct counting from a hemocytometer [26].
HBMEC culture
HBMEC were isolated and cultured as described pre-
viously [10]. HBMEC cultures were maintained in RPMI
1640 medium containing 10% heat-inactivated fetal
bovine serum, 10% NuSerum (BD Bioscience, Bedford,
MA), 2 mM glutamine, 1 mM sodium pyruvate, 100 μg/
ml streptomycin, 100 units/ml penicillin, essential
amino acids, and vitamins. The cells were washed before
performing experiments. The expression vector with the
Cav1-GFP was obtained from Addgene, Inc (plasmid
#14433). The plasmid was transfected into HBMEC
using neomycin for selection.
Immunofluorescence microscopy
Samples for immunofluorescence microscopy were pre-
pared as follows. HBMEC were plated onto glass cover-
slips (22 mm, square), which had been previously coated
with type I collagen from rat tail (Upstate, 5-10 μg/cm
2)
in an 8-well square culture system (Nalgene Nunc).
HBMEC (~5 × 10
4 cells) were seeded onto one coverslip
24 h prior to the experiment. HBMEC were prewashed
four times with PBS, then fixed with 2% formaldehyde/
PBS (v:v) for 30 min at room temperature. After addi-
tional three-washes with PBS, the HBMEC were blocked
with 5% milk/PBS for 30 min and then incubated with
antibody or proper reagent at 4°C overnight. Anti-CD44
monoclonal antibody was purchased from Santa Cruz
(used at 1:500 dilution); Cholera toxin subunit B
(CTxB)-FITC was purchased from Sigma Chem. Co.
(#C1655, 1~2 μg/mL); anti-Cav1(tyr-14) was purchased
from Cell Signaling Technology (#3251); actin filaments
were stained with phalloidin-rhodamine conjugate
(Sigma Chem Co. cat #P1951), and anti-tubulin antibody
was obtained from Sigma Chem Co., (#T5168). Anti-
GXM monoclonal antibody 18B7 was used to stain the
fungal cell (kindly provided by Dr. Casadevall, Albert
Einstein College of Medicine). The coverslips were then
washed 4 times with PBS, then 1% BSA/PBS and/or
anti-mouse IgG FITC conjugate (1:100 dilution) was
added into each well for 1 h at 4°C. Another three
washes were applied, then a drop of Vectashield mount-
ing solution containing DAPI (Vector Laboratories;
H-120) was used to seal the coverslips onto slides. Sam-
ples were examined under a fluorescence microscope at
the Congressman Dixon Cellular Imaging Core Facility,
Children’s Hospital Los Angeles.
In vitro adhesion and invasion assays
Immunofluorescence microscopy was used for the in vitro
adhesion and invasion assays, as described previously [10].
Briefly, the HBMEC were probed with b-actin using phal-
loidin-rhodamine conjugate to display a red background.
C. neoformans C1186 cells show a bright green fluores-
cence. After 3 hr incubation, the slides were prepared for
immunofluorescence imaging. Individual green C. neofor-
mans cells were observed clearly by immunofluorescence
microscopy. For those adherent C. neoformans cells, the
green signals from C1186 partially overlapped with the
red-stained HBMEC and thus displayed the green/yellow
signals. For invaded C. neoformans cells, the internalized
C. neoformans cells bearing GFP were totally overlapped
with red background and thus showed a complete yellow
signal. The total adherent (Figure 3A) or invaded (Figure
3B) C. neoformans cells of the untreated samples were
designated as 100%. Five random regions in the chamber
slide in each sample were counted under the microscope.
The assay for each experiment was reproduced at least 3
times.
In vitro transcytosis assay
C. neoformans in vitro transcytosis assays were performed
as described previously [14,15]. Briefly, HBMEC were
cultured on collagen-coated Transwell polycarbonate tis-
sue culture inserts with a pore diameter of 12 μm (Corn-
ing Costar) for 24 h. Triple samples of HBMEC were
pretreated with Cav1 siRNA (0, 10 and 20 pmoles in
0.5 mL culture medium) individually for an additional
48 h. HBMEC were polarized and exhibited a trans-
endothelial electrical resistance (TEER) of 250~300 μΩ
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2, as measured with an Endohm volt/ohm meter
(World Precision Instruments). On the morning of the
assay, HBMEC monolayers were washed with experimen-
tal medium and 10
6 Cryptococcus cells were added to the
upper chamber (total volume 500 μl); they were then
incubated at 37°C. At 4 and 8 h, samples (100 μl) were
taken from the lower chamber and plated for counting of
CFU. The lower chamber was replenished with 100 μl
fresh culture medium. Simultaneously, the integrity of
the HBMEC monolayer was assessed by measurement of
the TEER. Three measurements were made at each time-
point for each sample.
+ C1186 Normal
Mock
Cav1 siRNA-treated
Figure 1 Effect of CD44 membrane distribution on the Cav1 knockdown HBMEC. DAPI was used to stain nuclear DNA (blue) and CD44
was stained with the anti-CD44 monoclonal antibody and rhodamine conjugated secondary antibody (red). Top panel: membrane distributions
of CD44 without (left panel) or with (right panel) the incubation of green C. neoformans strain C1186. Lower panel: HBMEC were treated with
Cav1 siRNA in the presence (right column) or absence (left column) of C. neoformans cells (strain C1186). Magnified images were boxed and
shown in the bottom panel. Bar: 20 μm.
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Figure 2 Effect of Cav1 siRNA on HBMEC. (A) A Western blot shows the Cav1 proteins from HBMEC with the following treatments: lane 1:
mock; lane 2: random oligonucleotides; and lane 3: Cav1 siRNA. (B) An immunofluorescence microscopic image shows the reduction of Cav1 in
the siRNA-treated HBMEC. Most cells show only DAPI stain, and one HBMEC still has some Cav1 signals (red). (C) The membrane raft marker
ganglioside GM1 of HBMEC was stained with CTxB-FITC (green) and a C. neoformans cell (strain B-4500FO2) was stained with anti-GXM
monoclonal antibody and rhodamine conjugate (red) (lower panel). The upper panels (Mock) are the controls without incubation with C.
neoformans cells (strain B-4500FO2) (+Cn cells). The right column is HBMEC with Cav1 siRNA treatment (Cav1-KD) vs. the control (left column).
(D) The Metamorph program associated with our fluorescence microscope was used to scan images with 5~10 random fields, and then used
the statistical package GradPad Prime 5 to quantitate the readings. Analysis of variance shows significant increases in the GM1 signals in the
presence of C. neoformans cells (P = 0.0029), but no different in the siRNA treated samples.
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Cav1 siRNA was purchased from Santa Cruz Biotech
(#sc-29241), and a control oligo (#sc-36869) was used in
parallel as the control. Cav1 siRNA treatment is accord-
ing to the manufacturer’s protocol. Briefly, 0, 10, 20
pmoles siRNA (or indicated concentrations) was trans-
fected into HBMEC, using SuperFection TM siRNA
Transfection Reagent (cat.# SL100559) from SignaGen
®
Lab (Gaithsburg, MD). After 5 h, the culture was
replaced with fresh medium and grown for another 24
h. Then the HBMEC were washed with PBS three times
before the experiments. One set of sample was used to
detect the Cav1 protein level (Figure 2A), and another
set of treated HBMEC was used for several studies.
Similar preparations were performed for immunofluor-
escence microscopic studies (Figures 1, 2B, & 2C), in
vitro adhesion and invasion assays (Figure 3), and the
transcytosis assay (Figure 4).
Statistical analysis
The statistical analysis of the data from our in vitro stu-
dies involved analysis of variance (ANOVA). The depen-
dent variable was the associated percent of cells or CFU
while the independent fixed factors were the treatments
(Cav1 siRNA). Raw data was entered into EXCEL files
and automatically converted to statistical packages.
ANOVA and co-variates were followed by the New-
mann-Keuls test, to determine the statistical significance
between the control and treatment groups. P < 0.05 was
considered to be significant.
Results
Colocalization of Cav1-GFP and CD44 on the surface of
HBMEC
We have previously demonstrated that the HBMEC CD44
plays the key role as the host receptor during C. neofor-
mans invasion [14]. Upon C. neoformans association, both
CD44 and Cav1 translocate to the surface membrane rafts.
However, the relationship between CD44 and Cav1 is still
not clear. As Cav1 is a major structural and functional
protein component of caveolae/lipid rafts, we would like
to clarify the relationship of these two proteins during
C. neoformans infection. We first detected whether there
is a colocalization between Cav1 and CD44 molecules on
the membrane of HBMEC. DAPI stain (blue) was used to
locate HBMEC cells (Figure 5a). Cav1-GFP has been veri-
fied as a reliable marker for endogenous Cav1 [21], thus
we used it to represent its localization (Figure 5b). In gen-
eral, Cav1 can be found on the plasma membrane, peri-
centrosomal caversomes around the nucleus, and caveolae
vesicles in the cytosol. Its localization in HBMEC is similar
Figure 3 Effect of C. neoformans on the adhesion and invasion of HBMEC in the Cav1 knockdown HBMEC. HBMEC cells were pretreated
with (1) mock, (2) random oligo control, and (3) Cav-1 siRNA, before (A) the adhesion and (B) the invasion analyses. The treated samples were
incubated C. neoformans strain C1186 (10
5 cells) for 3 hr and then the slides were prepared for immunofluorescence imaging (see Materials and
Methods). The mock sample (lane 1) was designated as 100%, and the effects of siRNA were indicated by percentage over the control,
respectively. Each bar represents the average of four different experiments ± SD with P < 0.01. Detailed adhesion and invasion assays are
described in Materials and Methods.
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Figure 4 Effect of Cav1-knockdown HBMEC on C. neoformans
transmigration across the monolayer. HBMEC (10
4 cells) were
seeded on the collagen-coated transwells for four days, until
transendothelial electric resistance (TEER) reached > 250 μΩ/cm
2.
The coated cultures were treated with control oligo or Cav1 siRNA,
either 10 or 20 pmoles, in the 0.5 mL upper chamber, for 2 days
before the transcytosis studies. CFU were counted from the lower
chamber of the transwell at 4 and 8 h after the addition of C.
neoformans (n = 3). Analysis of variance shows significant decreases
in transcytosis ability in the Cav1 knockdown HBMEC (P = 0.011).
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on the plasma membrane and in the cytosol (Figure 5c). In
an overlaid image, there are colocalizations of Cav-1-GFP
and CD44 in some areas on the plasma membrane
(10~15%) (Figure 5d, arrows), as illustrated by the bright
yellow signals. No or little colocalization of CD44 and
Cav1 was observed inside the HBMEC.
Effect of anti-Cav1 siRNA on HBMEC during C. neoformans
infection
Infection of C. neoformans into HBMEC first requires
initial adherence to the host cell surface resulting in the
triggering of the host cell’s signaling pathway(s) to facili-
tate its internalization. We investigated whether the
knockdown of Cav1 with siRNA would affect CD44
function and/or C. neoformans invasion into HBMEC. A
random oligo and buffer alone were used in parallel as
controls. After 24 h of treatment, one set of samples
was used to detect the Cav1 protein level (Figure 2A).
Under our experimental conditions, ~60% of the endo-
genous Cav1 was knocked down in the Cav1 siRNA-
treated HBMEC (Figure 2A, lane 3) compared to the
controls (Figure 2A, lanes 1 & 2). Another set of sam-
ples was used for immunofluorescence images to exam-
ine Cav1 using anti-Cav1 antibodies with rhodamine
conjugate (red) in the Cav1-knockdown HBMEC. As
s h o w ni nF i g u r e2 B ,t h e r ea r es e v e r a lD A P Is t a i n sv o i d
of Cav1 signals; presumably these are Cav1-knockdown
HBMEC cells. Although limited, Cav1 signal can be
detected in some HBMEC cells. These signals are either
significantly reduced or display a more diffused distribu-
tion in HBMEC. The overall reduction of Cav1 signal is
consistent with protein blotting studies (Figure 2A).
To further examine the alterations in Cav1-knock-
down HBMEC, we used cholera toxin subunit B
(CTxB)-FITC conjugate to locate the membrane raft
marker ganglioside GM1. In the absence of C. neofor-
mans, the GM1 signal was weak (Figure 2C, left, upper
panel). Correspondingly, the signal increases, particularly
on the membrane portion, in the presence of C. neofor-
mans. However, in the Cav1 siRNA-treated HBMEC,
the signal of GM1 was weak and void of membrane
staining (Figure 2C, right panels). Despite the signal
increases in the presence of C. neoformans cells, there is
no noticeable redistribution of GM1 on the surface of
Cav1 KO HBMEC in the siRNA treated HBMEC (Figure
2C, right panels). Analysis of variance shows significant
increases in GM1 signal in the presence of C. neofor-
mans cells (P = 0.0029), but not much different in the
siRNA treated samples (Figure 2D). Thus, lack of Cav1
might prevent the reorganization of membrane lipid
rafts of HBMEC in response to C. neoformans infection.
Perturbation of CD44 distribution on HBMEC plasma
membrane after Cav1 siRNA treatment
We next explored if there was any effect on the distri-
bution of CD44 on the Cav1 knockdown HBMEC.
Through the immunofluorescent staining, the control
(CD44 without C. neoformans cells) is depicted by a
vivid contour on the membrane (Figure 1, upper, left
panel). In contrast, the CD44 signals increase and clus-
ters on the membrane in the presence of C. neoformans
strain C1186 cells (Figure 1, upper, right panel), particu-
larly around the C. neoformans adhesion site. Interest-
ingly, the Cav1 knockdown HBMEC displayed a very
unique phenotype i.e., the CD44 stains become irregu-
larly diffused throughout the surface (Figure 1, bottom
panels), regardless of the presence or absence of C. neo-
formans cells (Figure 1, left vs. right bottom panels).
The magnified images were displayed in the lower bot-
tom panels. It seems that CD44 loses its organization
and becomes concentrated in islands on the surface of
Figure 5 Colocalization of Cav1-GFP and CD44 on the surface of HBMEC. HBMEC were transformed with Cav1-GFP (1b, green). DAPI was
used to stain nuclear DNA (1a, blue), and CD44 was stained with an anti-CD44 monoclonal antibody and Rhodamine conjugate (1c, red). An
overlaid image was displayed on the right, showing some yellow signals (1d, arrows).
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CD44 intensity seems unchanged. This unique pheno-
type leads us to inquire: (1) can these CD44 molecules
in the Cav1 siRNA-treated HBMEC still act as func-
tional receptors for the adherence of C. neoformans
cells, and (2) can C. neoformans cells still invade into
Cav1 siRNA-treated HBMEC? These questions are
addressed below.
Effect of Cav1 siRNA on the adhesion and invasion of C.
neoformans into HBMEC
We speculated that knockdown of Cav1 may have some
profound effects on the CD44 receptor function, there-
fore, we used in vitro adhesion and invasion assays to
study C. neoformans infection on Cav1 knockdown
HBMEC [14]. Untreated HBMEC or HBMEC treated
with control oligo were used in parallel (Figure 3A,
lanes 1 and 2). We found that the association of C. neo-
formans with HBMEC was reduced only slightly in the
Cav1 siRNA-treated HBMEC (Figure 3A, lane3). Pre-
sumably, C. neoformans cells can adhere to the surface
of HBMEC, as the CD44 molecules are still present. On
the other hand, the number of invaded fungal cells was
significantly reduced in Cav-1 siRNA-treated HBMEC
(Figure 3B, lane 3), suggesting that C. neoformans cells
attached on the surface of HBMEC but failed to interna-
lize into the Cav1 knockdown host cells. In this regard,
the interaction between fungal cells and the host CD44
appears to be effective; however, the Cav1 siRNA-dis-
rupted of caveolae/lipid raft structures may not be able
to organize into an effective fungal entry site. Alterna-
tively, the reduction of Cav1 molecules may not be able
to trigger sufficient host signaling for C. neoformans
internalization.
Effect of Cav1 siRNA on C. neoformans traversal across
the HBMEC monolayer in vitro
We have set up an in vitro blood-brain barrier model to
study how C. neoformans cells traverse the HBMEC
monolayer [10,14]. HBMEC were seeded on the col-
lagen-coated transwell filter and treated with the control
oligonucleotide and Cav1 siRNA in parallel for compari-
son. The transendothelial electric resistance (TEER) was
used to monitor the intactness of the tight junction of
HBMEC monolayer. In general, the TEER was main-
tained around 250~300 μΩ throughout the experiments,
indicating that the tight junctions were maintained dur-
ing the study (data not shown). Our results showed the
ability of C. neoformans to traverse the monolayer was
significantly decreased in the absence of Cav1 (Figure
4), suggesting that Cav1 is crucial for the C. neoformans
penetration through the blood-brain barrier. Taken
together, our results support that Cav1 is not only
required for the integrity of membrane raft structure
(Figure 1), but also responsible for C. neoformans inter-
nalization (Figures 3). These functions are crucial for C.
neoformans cells to cross the blood-brain barrier (Figure
4), a process which may subsequently lead to central
nervous system infection.
Distribution of phosphorylated Cav1 on HBMEC during C.
neoformans infection
It has been suggested that, upon external stimulus,
caveolin may be activated through its phosphorylation
regulation [27,28]. Limited information is available
regarding the Cav1 phosphorylation regulation in rela-
tion to pathogen invasions [29]. So, we explored this
regulation in HBMEC during C. neoformans infection.
We first performed the time-course studies of Cav1 dur-
ing C. neoformans infection to evaluate its phosphoryla-
tion in HBMEC. Using anti-phospho-Tyr-14 Cav1
specific antibodies, we detected a basal level of phos-
phorylated Cav1 (Pi-Cav1) at the zero time point, sug-
gesting that the internalization of caveolae is already
active for certain normal cellular functions in HBMEC
(Figure 6A). Upon C. neoformans treatment, the Pi-Cav1
increased at 5 min and peaked at least 5-fold above
basal level at 10 min. Thus, C. neoformans is able to sig-
nificantly induce Cav1 phosphorylation, presumably
resulting in its activation.
We further used immunofluorescence microscope to
investigate the Pi-Cav1 dynamics in response to C. neo-
formans infection. In the absence of C. neoformans,t h e
basal level of the Pi-Cav1 could be observed in the peri-
nuclear regions in the cytosol (Figure 6B-1). Unlike total
Cav1 distribution shown in Figure 5, little or no Pi-Cav1
signal was detected in the plasma membrane of
H B M E C .I nt h ep r e s e n c eo fC. neoformans (5 min),
some membrane signals can be detected, but more sig-
nificantly, many linear array structures of Pi-Cav1 sig-
nals were observed inside the HBMEC (Figure 6B-2). In
a prolonged incubation (60 min), a mixed population of
Pi-Cav1 staining can be observed (Figure 6B-3). In some
cells, the cytosolic Pi-Cav1 displayed small vesicle struc-
tures (dots); however, the linear arrays are more
obvious. In other cells, the perinuclear localization can
be observed, suggesting the terminal location of Pi-
Cav1. Thus, membrane Cav1 may be phosphorylated,
internalized and accumulated in the perinuclear region
of HBMEC. The linear structure may represent its func-
tions in shuttling caveolae or caveolae-like membrane
vesicles between plasma membrane and caveosome
around the peri-centrosomal region [30].
To further examine its phosphorylation regulation,
C. neoformans isogenic CPS1 strains were used. C. neo-
formans strain B-4500FO2 (CPS1
+)c o u l d ,b u ts t r a i n
C559 (cps1Δ) could not, enhance the Pi-Cav1 signal
(Figure 7A). Since C559 is defective in the biosynthesis
Long et al. Journal of Biomedical Science 2012, 19:19
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itself could stimulate the phosphorylation of Cav1. As
s h o w ni nF i g u r e7 A( l i n e s4 ,5 ) ,t h eC a v 1p h o s p h o r y l a -
tion was increased in a hyaluronic acid-dependent man-
ner. Thus, phosphorylation regulation of Cav1 is an
HA-CD44 dependent process.
Filipin was used to perturb the membrane lipid raft
structure on HBMEC. Cav1 phosphorylation was stimu-
lated by C. neoformans B-4500FO2 first, but this
induced phosphorylation level was decreased as the fili-
pin concentration increased (Figure 7B). Therefore, the
filipin treatment reduced an already induced level of
phophorylation, and/or prevented the C. neoformans-
induction of phosphorylation. These results suggest that
Cav1 phosphorylation might take place at the membrane
lipid rafts and/or that Cav1 phosphorylation requires an
intact membrane raft structure.
Colocalization of Pi-Cav1 with b-actin, but not with
tubulin, during internalization
During endocytosis, endosomal trafficking is required
both the actin cytoskeleton and microtubules [21]. How-
ever, how they are linked to Pi-Cav1 dynamics has never
been explored. To further explore the nature of the lin-
ear array structure observed in Figure 6B, we examined
the relationship between Pi-Cav1, actin and the microtu-
bules. HBMEC were incubated with B-4500FO2 (CPS1
+)
at 0, 5 and 60 min and then probed for nuclear DNA,
b-actin and Pi-Cav1. DAPI stains nuclear DNA (blue) to
locate the individual HBMEC cell (Figure 8, first col-
umn). b-Actin molecules were stained by the phalloidin-
rhodamine conjugate (red) (Figure 8, second column),
and Pi-Cav1 was stained with a specific antibody conju-
gated with FITC (green) (Figure 8, third column). At the
5 min incubation period, the effect of C. neoformans on
Figure 6 Induction of Cav1 phosphorylation during C. neoformans infection. (A) HBMEC were infected with C. neoformans B-4500FO2 for
different time periods, and then cell lysates (50 μg) were blotted and probed with an anti-phospho-Cav1 (Tyr-14) antibody. A time course study
of Cav1 phosphorylation at 0, 5, 10, and 30 min is shown. b-actin was used as the loading control (second row). The ECL films (protein blots)
were scanned by the software ImageMaster 2D Platinum 6.0 for quantitative and graphic analyses (lower panel). The total intensity of all bands
is 100%. The relative intensity of the bands is indicated on the y-axis (n = 3). (B) Distribution of Pi-Cav1 during C. neoformans infection was
examined by immunofluorescence microscopy. Untreated HBMEC were used as the control (1), or the HBMEC monolayer was incubated with
10
6 C. neoformans strain B-4500FO2 for (2) 5 min and (3) 30 min. Pi-Cav1 was stained with anti-phospho-Cav1 (Tyr-14) and second antibody-FITC
conjugate (green). Nuclei were stained with DAPI (blue). Bar: 15 μm.
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observed. Both signals increased and thread-like struc-
tures became more obvious throughout the HBMEC.
The stress fibers of actin filaments are well known, but
the thread-like fibers of Pi-Cav1 have never been
described. At 60 min, similar structures could be
observed, except that b-actin showed stronger signals on
the plasma membrane, while Pi-Cav1 signals localized
more in the perinuclear region, presumably in caver-
somes around the pericentrosomal region. In all cases, a
colocalization of b-actin and Pi-cav1 on the plasma
membrane and pericentrosomal region close to the
nucleus, as thread-like structures, can be observed
(Figure 8, 4th column). This can be vividly observed as
the yellow/orange signals in the overlaid images. This
result raised an interesting possibility that the trafficking
of Pi-Cav1 may be linked to the b-actin cytoskeleton
system.
A similar study was performed to study the relation-
ship between tubulin and Pi-Cav1. Although tubulin
staining displayed a random, thread-like network
throughout the cytosol in HBMEC, there was no over-
lapping with Pi-Cav1’s long thread-like structures (Fig-
ure 8, bottom panels). In the perinuclear staining, there
m i g h tb es o m eo v e r l a pb e t w een Pi-Cav1 and tubulin,
but it was not significant. Thus, Pi-Cav1 trafficking
inside the HBMEC may be a microtubule-independent
process.
Discussion
C. neoformans needs to cross the BBB in order to infect
the central nervous system. Unraveling the biological
mechanism of C. neoformans invasion across the BBB is
crucial to understanding the microbial pathogenesis of
this disease. Previous reports have suggested that there
are several possible pathways for C. neoformans to enter
the host brain [7-9,11,12,14]. If multiple mechanisms
exist, then the important question is: which is the major
route of cerebral invasion by C. neoformans? Several in
vivo studies have provided clues to this mystery. For
example, C. neoformans cells could be found in mouse
brains after only 5 min following intravenous injection
with a low dose of pathogen (10
4 H99 cells per mouse)
[31]. But extravasation of horseradish peroxidase
through the BBB could only be detected in mouse
brains 6 h after injection with a high dose of pathogen
(10
7 H99 cells per mouse) [7]. Based on the above infor-
mation, damage to the tight junction or other paracellu-
lar mechanism may not be the major method that C.
neoformans uses to cross the BBB. In vitro, transmission
electron microscopic images show that C. neoformans
triggers the formation of microvillus-like membrane
protrusions in HBMEC within a short time (15 to 30
min), after which C. neoformans cells were internalized
by the cells. They penetrated across the HBMEC mono-
layers via a transcellular pathway without affecting
monolayer integrity [31]. One possible mechanism for
this is that fungal transcytosis may be mediated by the
fungal hyaluronic acid and host HBMEC CD44 receptor
[13,14]. Collectively, there is an active invasion process
(es) allowing fungal cells to effectively traverse the intact
BBB. To explore the mechanism of transcellular migra-
tion during cerebral invasion by C. neoformans,w es t u -
died the host response during this process. In this
report, we investigated the interplay among fungal cells,
Figure 7 Induction of Cav1 phosphorylation mediated by the
HA-CD44 pathway. (A) HBMEC were treated with 10
6 C.
neoformans strains B-4500FO2 (CPS1
+) or C559 (cps1Δ), or treated
with 1 and 2 μg hyaluronic acid (HA) for 10 minutes (A). The cell
lysates were prepared and immunoblotted for the detection of the
phosphorylated form of Cav1 (top row). b-actin was used as the
loading control (second row). The quantitative and graphic analyses
(lower panel) were described in the legend of Figure 6. (n = 4) (B)
HBMEC cells were pre-treated with filipin (0 to 5 ng) for 10 minutes
prior to the treatment of 10
6 C. neoformans strain B-4500FO2 cells.
The signals of Pi-Cav1 were then examined as described above.
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Page 10 of 14Figure 8 Immunofluorescence microscopy to examine phospho-Cav1 and b-actin localization during C. neoformans infection.T h e
HBMEC monolayers were incubated with 10
6 C. neoformans strain B-4500FO2 for 0 min, 5 min and 60 min. In parallel, untreated HBMEC were
used as a negative control, indicated as 0 min in the figure. b-Actin was stained with phalloidin-rhodamine conjugate (red) (second column) and
the phosphor-Cav1 was stained with anti-phospho-Cav1 (Tyr-14) antibody and second antibody-FITC conjugate (green). Nuclei were stained with
DAPI (blue). Bar: 15 μm. A similar study was performed in the bottom panel, in which tubulin was stained with anti-tubulin antibodies and
rhodamine conjugate (second column) at the 60 min incubation time point.
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the mechanism of adhesion and invasion by this fungus.
CD44 is the C. neoformans receptor on the lipid rafts/
caveolae of HBMEC [14]. Here we initially demonstrated
that CD44 was colocalized with Cav1 on the surface of
HBMEC (Figure 5), supporting the notion that CD44
exerts its functions on lipid rafts. Lipid rafts are enriched
in cholesterol, sphingolipids and raft proteins. These
highly dynamic membrane structures may have a poten-
tial role as signaling platforms by clustering receptors
used by pathogens. Caveolae are a special type of mem-
brane lipid rafts. We therefore investigated whether their
major component, Cav1, is involved in the C. neoformans
invasion process. We found that the lipid raft marker
ganglioside GM1 (Figure 2) can cluster around the
C. neoformans adhesion site. Knockdown of Cav1 per-
turbed GM1 distribution (Figure 2), and, more interest-
ingly, the CD44 proteins became randomly distributed
and clustered into irregular islands on the surface of
HBMEC (Figure 1B). This unique morphology has never
been described in any cell type. As such, C. neoformans
invasion into HBMEC is impaired (Figure 3B). The
results suggest that Cav1 may play an important struc-
tural role in the reorganization of CD44, optimizing
it to function as a receptor during C. neoformans inva-
sion. Furthermore, transcytosis of C. neoformans was sig-
nificantly reduced in the Cav1 knockdown HBMEC
(Figure 4). Together, CD44 might be anchored on the
lipid rafts/caveolae to form an entry site on the surface of
HBMEC during C. neoformans infection. At present,
there is no evidence to show a direct interaction between
CD44 and Cav1. On the other hand, it has been docu-
mented that there is a direct interaction between PKCa
and Cav1 [32], and that activation of PKCa on the
plasma membrane is required for C. neoformans invasion
into HBMEC [10]. The relationship between Cav1 and
PKCa for C. neoformans invasion is interesting, but still
needs to be further elucidated.
One interesting question regarding C. neoformans inva-
sion is that the C. neoformans cell is able to hijack the
endocytic signaling in HBMEC in order to facilitate its
internalization [16]. Notice that endocytosis comprises
multiple mechanisms, i.e., caveolae-dependent, clathrin-
dependent, pinocytosis, macropinocytosis, and phagocyto-
sis [17-20,30]. In this report, we first demonstrated the
involvement of Cav1 in C. neoformans infection. Perturba-
tion of Cav1 function by knockdown of Cav1 (Figures 3
and 4) can substantially reduce the ability of fungi to
invade HBMEC. Cav1 is the major protein constituent of
caveolae [23]. Thus, our results support the notion that C.
neoformans may utilize the lipid raft/caveolae endocytic
pathway for its invasion. Caveolae are small invaginations
in the plasma membrane that mediate multiple functions,
including signal transduction and endocytosis [19,30].
Increasing evidence shows that pathogens are able to use
lipid rafts or caveolae as cell surface platforms for interact-
ing with, binding to and possibly entering into the host
cells [33]. Typical caveolae are 70 to 100 nm in diameter.
Sphingolipid binding toxins (cholera toxin CTxB and
shiga toxin) and viruses (including SV40) can be carried
inside the caveolae cargo, whereas bacteria (> 1 μmi nd i a -
meter) are much larger than caveolae, which might thus
not be suitable to accommodate their engulfment. In this
case, the caveolae do not provide the entry route per se
[34], but offer signaling platforms required for the bacter-
ial invasion. The size of C. neoformans is ~5 μm or larger
in diameter, depending on its capsule size. It is conceivable
that entry of this organism is mediated by its association
with lipid rafts, rather than by its enclosure within caveo-
lae per se, and that host Cav1 plays a crucial role of C. neo-
formans invasion into HBMEC.
We further studied how Cav1 was involved in this inva-
sion process. It has been proposed that, upon the ligand
interaction, Cav1 is activated through its phosphorylation
regulation [27,28]. However, the regulation of Cav1 by
phosphorylation is poorly understood in the field of the
pathogen infection. In our studies, we have found several
novel observations about Cav1 phosphorylation regulation.
First, phosphorylation of Cav1 is enhanced in the presence
of C. neoformans. The peak of phosphorylation is around
10 min at the fungal-host engagement (Figure 6), suggest-
ing that Cav1 is involved during the C. neoformans infec-
tion. Secondly, the Cav1 phosphorylation is HA-dependent
(Figure 7A), presumably, through the C. neoformans HA to
HBMEC CD44 signaling pathway.T h i r d l y ,p h o s p h o r y l a t i o n
apparently starts from the lipid rafts, as filipin treatment
can reduce its phosphorylation level (Figure 7B); thus, its
phosphorylation, most likely, triggers a dynamic internali-
zation process there. Fourthly, a major finding of our study
is that the Pi-Cav1 signal is observed as the thread-like
structure inside the HBMEC, and this structure is coloca-
lized with b-actin filaments, not with tubulin (Figure 8). It
is known that Cav1 can associate with many proteins
through its CSD domain, including actin-binding protein
such as filamin [35,36]. In this scenario, activated Cav1 (Pi-
Cav1) may be associated with b-actin through this binding
domain and internalized into HBMEC. It is tempting to
speculate that other signaling molecules may also be inter-
nalized via binding with Pi-Cav1 in a similar manner.
Thus, Pi-Cav1 may carry certain signaling molecules with
it during the internalization process. This speculation
remains to be demonstrated.
Conclusions
Our studies demonstrate that C. neoformans is able to
manipulate the lipid-raft/caveolae endocytic pathway to
facilitate its adhesion and internalization into HBMEC.
Cav1 may function as a plasma membrane platform to
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Page 12 of 14localize caveolin interacting signaling molecules within
caveolae membranes. Our results support a transcellular
mechanism for C. neoformans invasion. We are cur-
rently investigating Cav1-associated signaling molecules
and Cav1 regulation to unravel the profound invasion
mechanism of C. neoformans.
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